In vivoT-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia

(2011) J. C. Marsh et al.   BLOOD

Immune recovery after autologous PBSC transplantation without in vitro graft manipulation for refractory systemic lupus erythematosus

(2011) H Wada et al.   BONE MARROW TRANSPLANTATION

Alemtuzumab for the prevention and treatment of graft-versus-host disease

(2011) Junya Kanda et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution

(2010) R. Chakraverty et al.   BLOOD

Pharmacokinetics and clinical activity of very low-dose alemtuzumab in transplantation for acute leukemia

(2010) A Spyridonidis et al.   BONE MARROW TRANSPLANTATION

T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma

(2010) Kirsty J. Thomson et al.   JOURNAL OF CLINICAL ONCOLOGY

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

(2009) B. Patel et al.   HAEMATOLOGICA

Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation

(2008) Yuki Asano-Mori et al.   AMERICAN JOURNAL OF HEMATOLOGY

The Effect of In Vivo T Cell Depletion with Alemtuzumab on Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia

(2008) Julio Delgado et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma

(2008) Kirsty J. Thomson et al.   JOURNAL OF CLINICAL ONCOLOGY